The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis

被引：0
|
作者：
Merle, P
Zoulim, F
Vitvitski, L
Trépo, C
机构：
[1] INSERM, U271, Lab Rech Hepatites & Pathol Associees, F-69424 Lyon 03, France
[2] Hop Hotel Dieu, Serv Hepatogastroenterol, Lyon, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2000年 / 24卷 / 12期
关键词：
liver; hepatocellular carcinoma; interferon; carcinogenesis; prevention;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1166 / 1176
页数：11
相关论文
共 50 条
  • [21] Hepatitis B virus-induced hepatocellular carcinoma: The role of the virus x protein
    Motavaf, M.
    Safari, S.
    Jourshari, M. Saffari
    Alavian, S. M.
    ACTA VIROLOGICA, 2013, 57 (04) : 389 - 396
  • [22] Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Tanikawa, M
    Hisanaga, Y
    Hayashi, K
    Honda, T
    ONCOLOGY, 2001, 61 (02) : 134 - 142
  • [23] Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma
    Ramakrishnan, Krishnapriya
    Vishwakarma, Riya
    Dev, Radul R.
    Raju, Rajesh
    Rehman, Niyas
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2024, 28 (06) : 280 - 290
  • [24] Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
    Sanjit Boora
    Vikrant Sharma
    Sulochana Kaushik
    Ajoy Varma Bhupatiraju
    Sandeep Singh
    Samander Kaushik
    Brazilian Journal of Microbiology, 2023, 54 : 679 - 689
  • [25] Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem
    Boora, Sanjit
    Sharma, Vikrant
    Kaushik, Sulochana
    Bhupatiraju, Ajoy Varma
    Singh, Sandeep
    Kaushik, Samander
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2023, 54 (02) : 679 - 689
  • [26] Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years
    Lee, Hyun Jung
    Yeon, Jong Eun
    Yoon, Eileen L.
    Suh, Sang Jun
    Kang, Keunhee
    Kim, Hae Rim
    Kang, Seong Hee
    Yoo, Yang Jae
    Je, Jihye
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Byun, Kwan Soo
    INTERVIROLOGY, 2015, 58 (01) : 14 - 21
  • [27] Screening of potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma using bioinformatic analysis
    Liu, Jun
    Ma, Zhanzhong
    Liu, Yanming
    Wu, Liangyin
    Hou, Zhiwei
    Li, Wenli
    ONCOLOGY LETTERS, 2019, 18 (03) : 2500 - 2508
  • [28] Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis
    Testino, G
    Ansaldi, F
    Andorno, E
    Ravetti, GL
    Ferro, C
    De Iaco, F
    Icardi, G
    Valente, U
    HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1636 - 1638
  • [29] Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
    Ji, Junfang
    Yu, Lei
    Yu, Zhipeng
    Forgues, Marshonna
    Uenishi, Takahiro
    Kubo, Shoji
    Wakasa, Kenichi
    Zhou, Jian
    Fan, Jia
    Tang, Zhao-You
    Fu, Shijun
    Zhu, Hongguang
    Jin, Jason Gang
    Sun, Hui-Chuan
    Wang, Xin Wei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2013, 9 (03): : 303 - 312
  • [30] Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants
    Tong, H. V.
    Toan, N. L.
    Song, L. H.
    Bock, C. -T.
    Kremsner, P. G.
    Velavan, T. P.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (10) : 687 - 698
12345